 - Arm II: Patients receive fotemustine by a 4-hour intra-arterial IA hepatic perfusion on days 1, 8, 15, and 22 induction course. Beginning on day 57, patients receive maintenance courses of fotemustine by a 4-hour IA hepatic perfusion every 21 days in the absence of disease progression or unacceptable toxicity. 